Form 4: Tenet Healthcare Director Christopher Lynch Boosts Common Stock Holdings Through RSU Conversion and New Grant

Tenet Healthcare Corp. Director Christopher S. Lynch increased his direct beneficial ownership of common stock to 16,310 shares following the conversion of 1,551 restricted stock units and the grant of an additional 1,333 restricted stock units.

Summary

• Christopher S. Lynch, a Director of Tenet Healthcare Corp. (THC), reported changes in his beneficial ownership of company securities.
• On May 23, 2025, Mr. Lynch converted 1,551 Restricted Stock Units (RSUs) into 1,551 shares of Tenet Healthcare Corp. Common Stock.
• Following this conversion, Mr. Lynch's direct beneficial ownership of Common Stock increased to 16,310 shares.
• Additionally, on May 22, 2025, Mr. Lynch was granted 1,333 new Restricted Stock Units under the Company's Stock Incentive Plan.
• These newly granted RSUs are the economic equivalent of one share of common stock each and are set to vest on May 22, 2026.
• The reporting person has the option to elect to receive up to 37% of these restricted stock units in cash instead of shares.

Sentiment

Score: 7

Explanation: The sentiment is positive as it indicates a director's continued alignment with shareholder interests through the acquisition of new restricted stock units and the conversion of existing units into common stock, increasing direct share ownership. This is a routine, positive signal of insider commitment.

Positives

• The conversion of Restricted Stock Units into common stock increases the director's direct equity stake, aligning his interests more closely with shareholders.
• The grant of new Restricted Stock Units indicates continued compensation and retention of a key director, reflecting ongoing commitment to the company.

Future Outlook

The document does not provide forward-looking statements or guidance beyond the vesting schedule of the newly granted restricted stock units.

Industry Context

This Form 4 filing reflects routine insider compensation and equity management practices common across publicly traded companies, including those in the healthcare services sector. It demonstrates the company's use of equity-based incentives to align director interests with long-term shareholder value.

Corporate Governance

Related Party Transactions

• The reported transactions involve a director of Tenet Healthcare Corp. (Christopher S. Lynch) acquiring and converting company securities, which are considered related party transactions under SEC regulations.

Stakeholder Impact

• Shareholders: The increase in direct common stock ownership by a director can be viewed positively as it aligns management's interests with those of shareholders, potentially signaling confidence in the company's future performance.
• Employees: The use of a Stock Incentive Plan for director compensation suggests a broader framework for equity-based incentives that may also apply to other key personnel, potentially impacting employee retention and motivation.

Next Steps

• The 1,333 Restricted Stock Units granted on May 22, 2025, are expected to vest on May 22, 2026.

Key Dates

Keywords

Tenet Healthcare, THC, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Common Stock, Director Compensation, Stock Incentive Plan, Beneficial Ownership